AIDS

TES-STUDY-P012

Falutz J, Allas S, Mamputu J-C, et al. Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. AIDS. 2008. DOI: 10.1097/QAD.0b013e32830a5058. PMID: 18690162. https

Study design

Record details

Design: Human clinical and physiological evidence

Evidence record

Endpoints, findings, and limitations

Limitations

This study record is an evidence-index entry. Interpret the design, material, population or model, endpoints, findings, and limitations only within the linked approved source and compound evidence map; do not transfer outcomes across compounds, materials, cohorts, or models.

Reports and sources

Reference ledger

P012Human clinical and physiological evidence

AIDS

Falutz J, Allas S, Mamputu J-C, et al. Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. Falutz J, Allas S, Mamputu J-C, et al. Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. AIDS. 2008. DOI: 10.1097/QAD.0b013e32830a5058. PMID: 18690162. https://pubmed.ncbi.nlm.nih.gov/18690162/(2008). DOI: 10.1097/QAD.0b013e32830a5058